This Article Full Text Full Text (PDF) All Versions of this Article: 95/9/930    most recent 01.RES.0000147312.02673.56v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harris, S. P. Articles by Moss, R. L. Search for Related Content PubMed PubMed Citation Articles by Harris, S. P. Articles by Moss, R. L. Related Collections Contractile function Myocardial cardiomyopathy disease Animal models of human disease

(Circulation Research. 2004;95:930.)
© 2004 American Heart Association, Inc.

Cellular Biology

Binding of Myosin Binding Protein-C to Myosin Subfragment S2 Affects Contractility Independent of a Tether Mechanism

Samantha P. Harris, Elena Rostkova, Mathias Gautel, Richard L. Moss

From the Department of Bioengineering (S.P.H.), University of Washington, Seattle, Wash; Cardiovascular and Randall Divisions (E.R., M.G.), King’s College London, London, UK; and the Department of Physiology (R.L.M.), University of Wisconsin, Madison.

Correspondence to Samantha Harris, PhD, Department of Bioengineering, Box 357962, University of Washington, Seattle, WA 98195. E-mail spharris{at}u.washington.edu

Mutations in the cardiac myosin binding protein-C gene (cMyBP-C) are among the most prevalent causes of inherited hypertrophic cardiomyopathy. Although most cMyBP-C mutations cause reading frameshifts that are predicted to encode truncated peptides, it is not known if or how expression of these peptides causes disease. One possibility is that because the N-terminus contains a unique binding site for the S2 subfragment of myosin, shortened cMyBP-C peptides could directly affect myosin contraction by binding to S2. To test this hypothesis, we compared the effects of a C1C2 protein containing the myosin S2 binding site on contractile properties in permeablized myocytes from wild-type and cMyBP-C knockout mice. In wild-type myocytes, the C1C2 protein reversibly increased myofilament Ca²⁺ sensitivity of tension, but had no effect on resting tension. Identical results were observed in cMyBP-C knockout myocytes where C1C2 increased Ca²⁺ sensitivity of tension with the half-maximal response elicited at 5 µmol/L C1C2. Maximum force was not affected by C1C2. However, phosphorylation of C1C2 by cAMP-dependent protein kinase reduced its ability to increase Ca²⁺ sensitivity. These results demonstrate that binding of the C1C2 peptide to S2 alone is sufficient to affect myosin contractile function and suggest that regulated binding of cMyBP-C to myosin S2 by phosphorylation directly influences myofilament Ca²⁺ sensitivity.

Key Words: Ca²⁺ sensitization • myocardial contractility • cardiac muscle • cardiac myocytes • cardiomyopathy • transgenic mice

This article has been cited by other articles:

				B. A. Colson, T. Bekyarova, M. R. Locher, D. P. Fitzsimons, T. C. Irving, and R. L. Moss Protein Kinase A-Mediated Phosphorylation of cMyBP-C Increases Proximity of Myosin Heads to Actin in Resting Myocardium Circ. Res., August 1, 2008; 103(3): 244 - 251. [Abstract] [Full Text] [PDF]

				Y. Lecarpentier, N. Vignier, P. Oliviero, A. Guellich, L. Carrier, and C. Coirault Cardiac Myosin-Binding Protein C Modulates the Tuning of the Molecular Motor in the Heart Biophys. J., July 15, 2008; 95(2): 720 - 728. [Abstract] [Full Text] [PDF]

				R. W. Kensler and S. P. Harris The Structure of Isolated Cardiac Myosin Thick Filaments from Cardiac Myosin Binding Protein-C Knockout Mice Biophys. J., March 1, 2008; 94(5): 1707 - 1718. [Abstract] [Full Text] [PDF]

				V. S. Rao, L. R. La Bonte, Y. Xu, Z. Yang, B. A. French, and W. H. Guilford Alterations to myofibrillar protein function in nonischemic regions of the heart early after myocardial infarction Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H654 - H659. [Abstract] [Full Text] [PDF]

				M. V. Razumova, J. F. Shaffer, A.-Y. Tu, G. V. Flint, M. Regnier, and S. P. Harris Effects of the N-terminal Domains of Myosin Binding Protein-C in an in Vitro Motility Assay: EVIDENCE FOR LONG-LIVED CROSS-BRIDGES J. Biol. Chem., November 24, 2006; 281(47): 35846 - 35854. [Abstract] [Full Text] [PDF]

				J. E. Stelzer, D. P. Fitzsimons, and R. L. Moss Ablation of Myosin-Binding Protein-C Accelerates Force Development in Mouse Myocardium Biophys. J., June 1, 2006; 90(11): 4119 - 4127. [Abstract] [Full Text] [PDF]

				T. J. Herron, E. Rostkova, G. Kunst, R. Chaturvedi, M. Gautel, and J. C. Kentish Activation of Myocardial Contraction by the N-Terminal Domains of Myosin Binding Protein-C Circ. Res., May 26, 2006; 98(10): 1290 - 1298. [Abstract] [Full Text] [PDF]

				J. E. Stelzer, S. B. Dunning, and R. L. Moss Ablation of Cardiac Myosin-Binding Protein-C Accelerates Stretch Activation in Murine Skinned Myocardium Circ. Res., May 12, 2006; 98(9): 1212 - 1218. [Abstract] [Full Text] [PDF]

				O. Cazorla, S. Szilagyi, N. Vignier, G. Salazar, E. Kramer, G. Vassort, L. Carrier, and A. Lacampagne Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice Cardiovasc Res, February 1, 2006; 69(2): 370 - 380. [Abstract] [Full Text] [PDF]

				H.-P. Vosberg The ubiquitin-proteasome system may be involved in the pathogenesis of hypertrophic cardiomyopathy Cardiovasc Res, April 1, 2005; 66(1): 1 - 3. [Full Text] [PDF]